Cardiovascular Journal of Africa: Vol 28 No 6 (November/December 2017)

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 6, November/December 2017

AFRICA

369

14. Contreras-Alcantara S, Baba K, Tosini G. Removal of melatonin

receptor type 1 induces insulin resistance in the mouse.

Obesity (Silver

Spring)

2010; 18: 1861–1863.

15. Lima FB, Machado UF, Bartol I,

et al

. Pinealectomy causes glucose

intolerance and decreases adipose cell responsiveness to insulin in rats.

Am J Physiol Endocrinol Metab

1998; 275: E934–941.

16. Xia Q, Chen ZX, Wang YC,

et al

. Association between the melatonin

receptor 1B gene polymorphism on the risk of type 2 diabetes, impaired

glucose regulation: A meta-analysis.

PLoS One

2012;

(11): e50107.

17. Ronn T, Wen J, Yang Z,

et al.

A common variant in MTNR1B, encoding

melatonin receptor 1B, is associated with type 2 diabetes and fasting plas-

ma glucose in han chinese individuals.

Diabetologia

2009;

: 830–833.

18. McMullan CJ, Schernhammer ES, Rimm EB, Hu FB, Forman JP.

Melatonin secretion and the incidence of type 2 diabetes.

J Am Med

Assoc

2013;

309

: 1388–1396.

19. McMullan CJ, Curhan GC, Schernhammer ES, Forman JP. Association

of nocturnal melatonin secretion with insulin resistance in nondiabetic

young women.

Am J Epidemiol

2013;

178

: 231–238.

20. Prokopenko I, Langenberg C, Florez JC,

et al.

Variants in MTNR1B

influence fasting glucose levels.

Nat Genet

2009;

: 77–81.

21. Wan X, Li S, Xi S, Wang J, Guo Y, Wang X. Long-term melatonin

administration improves glucose homeostasis and insulin resistance

state in high-fat-diet fed rats.

Cent Eur J Biol

2013;

: 958–967.

22. Shieh JM, Wu HT, Cheng KC, Cheng JT. Melatonin ameliorates high fat

diet-induced diabetes and stimulates glycogen synthesis via a PKCzeta-

akt-GSK3beta pathway in hepatic cells.

J Pineal Res

2009;

: 339–344.

23. Kitagawa A, Ohta Y, Ohashi K. Melatonin improves metabolic syndrome

induced by high fructose intake in rats.

J Pineal Res

2012;

: 403–413.

24. She M, Deng X, Guo Z,

et al

. NEU-P11, a novel melatonin agonist,

inhibits weight gain and improves insulin sensitivity in high-fat/high-

sucrose-fed rats.

Pharmacol Res

2009;

: 248–253.

25. Karamitri A, Renault N, Clement N, Guillaume J, Jockers R.

Minireview: toward the establishment of a link between melatonin and

glucose homeostasis: Association of melatonin MT2 receptor variants

with type 2 diabetes.

Molec Endocrinol

2013;

: 1217–1233.

26. Wright JJ, Kim J, Buchanan J,

et al.

Mechanisms for increased

myocardial fatty acid utilization following short-term high-fat feeding.

Cardiovasc Res

2009; 82: 351–360.

27. Cook SA, Varela-Carver A, Mongillo M,

et al

. Abnormal myocardial

insulin signalling in type 2 diabetes and left-ventricular dysfunction.

Eur

Heart J

2010;

: 100–111.

28. Zanuto R, Siqueira-Filho MA, Caperuto LC,

et al.

Melatonin improves

insulin sensitivity independently of weight loss in old obese rats.

J Pineal

Res

2013;

: 156–165.

29. Anhe GF, Caperuto LC, Pereira-Da-Silva M,

et al. In vivo

activation of

insulin receptor tyrosine kinase by melatonin in the rat hypothalamus.

Neurochem

2004;

: 559–566.

30. Agil A, El-Hammadi M, Jimenez-Aranda A,

et al.

Melatonin reduces

hepatic mitochondrial dysfunction in diabetic obese rats.

J Pineal Res

2015;

: 70–79.

31. Ghosh G, De K, Maity S,

et al

. Melatonin protects against oxidative

damage and restores expression of GLUT4 gene in the hyperthyroid rat

heart.

J Pineal Res

2007;

: 71–82.

32. Nduhirabandi F, du Toit EF, Blackhurst D, Marais D, Lochner A.

Chronic melatonin consumption prevents obesity-related metabolic

abnormalities and protects the heart against myocardial ischemia and

reperfusion injury in a prediabetic model of diet-induced obesity.

Pineal Res

2011;

: 171–182.

33. Nduhirabandi F, Huisamen B, Strijdom H, Blackhurst D, Lochner A.

Short-term melatonin consumption protects the heart of obese rats

independent of body weight change and visceral adiposity.

J Pineal Res

2014;

: 317–332.

34. Huisamen B, Donthi RV, Lochner A. Insulin in combination with vana-

date stimulates glucose transport in isolated cardiomyocytes from obese

zucker rats.

Cardiovasc Drugs Ther

2001;

: 445–452.

35. Huisamen B, Dietrich D, Bezuidenhout N,

et al.

Early cardiovascular

changes occurring in diet-induced, obese insulin-resistant rats.

Mol Cell

Biochem

2012;

368

: 37–45.

36. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement

with the folin phenol reagent.

J Biol Chem

1951;

193

: 265–275.

37. Fueger PT, Shearer J, Bracy DP,

et al

. Control of muscle glucose uptake:

Test of the rate-limiting step paradigm in conscious, unrestrained mice.

J Physiol

2005;

562

: 925–935.

38. Alonso-Vale MI, Anhe GF, Borges-Silva CN,

et al.

Pinealectomy alters

adipose tissue adaptability to fasting in rats.

Metabolism

2004;

500–506.

39. Teodoro BG, Baraldi FG, Sampaio IH,

et al.

Melatonin prevents mito-

chondrial dysfunction and insulin resistance in rat skeletal muscle.

Pineal Res

2014;

: 155–167.

40. Cantwell EL, Cassone VM. Daily and circadian fluctuation in 2-deoxy

[14C]-glucose uptake in circadian and visual system structures of the

chick brain: Effects of exogenous melatonin.

Brain Res Bull

2002;

603–611.

41. Banerjee A, Udin S, Krishna A. Regulation of leptin synthesis in white

adipose tissue of the female fruit bat, cynopterus sphinx: role of mela-

tonin with or without insulin.

Exp Physiol

2011;

: 216–225.

42. Wang P, She M, He P,

et al

. Piromelatine decreases triglyceride accumu-

lation in insulin resistant 3T3-L1 adipocytes: Role of ATGL and HSL.

Biochimie

2013;

: 1650–1654.

43. Carroll R, Carley AN, Dyck JR, Severson DL. Metabolic effects of

insulin on cardiomyocytes from control and diabetic db/db mouse

hearts.

Am J Physiol Endocrinol Metab

2005;

288

: E900–E906.

44. Owino S, Contreras-Alcantara S, Baba K, Tosini G. Melatonin signaling

controls the daily rhythm in blood glucose levels independent of periph-

eral clocks.

PloS One

2016;

: e0148214.

45. Mueckler M, Thorens B. The SLC2 (GLUT) family of membrane trans-

porters.

Mol Aspects Med

2013;

: 121–138.

46. Rios-Lugo MJ, Cano P, Jimenez-Ortega V,

et al

. Melatonin effect on

plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol

in normal and high fat-fed rats.

J Pineal Res

2010;

: 342–348.

47. Zanquetta MM, Seraphim PM, Sumida DH, Cipolla-Neto J, Machado

UF. Calorie restriction reduces pinealectomy-induced insulin resist-

ance by improving GLUT4 gene expression and its translocation to the

plasma membrane.

J Pineal Res

2003;

: 141–148.

48. Faria JA, Kinote A, Ignacio-Souza LM,

et al

. Melatonin acts through

MT1/MT2 receptors to activate hypothalamic AKT and suppress

hepatic gluconeogenesis in rats.

Am J Physiol Endocrinol Metab

2013;

: E230–242.

49. Montessuit C, Lerch R. Regulation and dysregulation of glucose trans-

port in cardiomyocytes.

Biochim Biophys Acta

2013;

1833

: 848–856.

50. Dominguez-Rodriguez A, Abreu-Gonzalez P, Arroyo-Ucar E, Reiter

RJ. Decreased level of melatonin in serum predicts left ventricular

remodelling after acute myocardial infarction.

J Pineal Res

2012;

319–323.

51. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia MJ, Sanchez J,

Marrero F, de Armas-Trujillo D. Decreased nocturnal melatonin levels

during acute myocardial infarction.

J Pineal Res

2002;

: 248–252.

52. Fields AV, Patterson B, Karnik AA, Shannon RP. Glucagon-like

peptide-1 and myocardial protection: More than glycemic control.

Clin

Cardiol

2009;

: 236–243.